About 20 percent of COVID-19 patients in intensive care units in New York City are in need of dialysis, according to the report. COVID-19 patients, who are often also on ventilators, often require the kidney treatment for days, if not weeks.
Several New York hospital systems, including NYC Health + Hospitals and Mount Sinai Health System, met this week to discuss the emerging dialysis fluid crisis and some solutions.
Some hospitals in New York said they are facing dire shortages of the dialysis fluid and have reached out directly to dialysis fluid manufactures for help, according to Politico.
The Federal Emergency Management Agency held a call this week with the FDA and CMS to discuss ways of boosting dialysis fluid supplies, including using an emergency authorization to import more.
Access the full report here.
More articles on supply chain:
COVID-19 testing in the US: 6 questions answered
US doubles hospital payments to speed processing of Abbott COVID-19 tests
Create a national distribution system for protective gear, AMA urges
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
